Chronic constipation affects the quality of life of more than 150 million people in Europe and the United States. Although laxatives may appear to be a good solution for occasional constipation, their use in treating chronic constipation is not indicated. Laxatives not only lose their effect over time, they also have adverse effects and are addictive.
Regular use of laxatives can lead to dysfunctional bowel motility such as intestinal paralysis, cathartic colon, vagus bowel syndrome, irritable bowel syndrome, or pancreatitis. Abuse of laxatives can lead to complications such as these or other problems. It is therefore important to use them sparingly and under the supervision of a physician or other regulated healthcare professional.
People who suffer chronic constipation, that means, are constipated daily or more than once a week, should not self-medicate with laxatives.
Survey on treatments for chronic constipation
In 2013, Dr. Müller-Lissner, a prestigious German gastroenterologist, published the results of a survey on the degree of satisfaction with the treatment of chronic constipation carried out in 10 European countries.
The study involved 1,355 patients with chronic constipation, of whom 921 reported using laxatives, that is, 68% of the participants in the study. Among them, only 28% responded that they were satisfied with the pharmacological treatment. Another 28% confessed their dissatisfaction with the use of laxatives and the remaining 44% was declared neutral.
In addition, 83% said they are very interested in finding better solutions to treat their constipation.
How was MOWOOT developed?
MOWOOT was created by usMIMA’s team of scientists and engineers in response to the dissatisfaction of chronic constipation patients with current remedies such as laxatives, that are only useful for relieving episodes of constipation but unsuitable for treating a chronic condition.
In addition, alleviating constipation is very costly for patients who suffer chronic constipation. As usMIMA CEO Markus Wilhelms explained in the EIT Health Spain Award, a chronic constipation patient can easily spend € 700 a year on laxatives. If you treat constipation with enemas, the annual cost rises to € 2,300 and even € 35,000 if you opt for a more sophisticated and very invasive solution such as SARS, a neurostimulating implant.
The MOWOOT device, created with the collaboration of the neuro-rehabilitation center Institut Guttmann, is an innovative alternative to the current remedies for constipation. It is a pneumatic belt that rhythmically presses the abdomen following the course of the colon (ascending and descending) according to a patented algorithm.
This specific therapy has been inspired by the abdominal massage applied by professional therapists to facilitate the evacuation of feces.
In short, MOWOOT is a solution to chronic constipation that does not generate the complications of other pharmacological or invasive solutions, contraindicated for chronic patients. Unlike laxatives, which lose their effectiveness over time, MOWOOT increases its effects with each use. To reach its maximum level of effectiveness, the treatment should be administered daily for a period of 10 to 20 minutes.
The effectiveness of MOWOOT has been proven in a clinical study that was presented at the last annual Congress of the Society of Geriatric Medicine of the European Union.